Project Twenty21 - May Update

In this update, we reveal the first paper to be published from Project Twenty21! We also share the latest data and patient experiences, as well as a video showing what it’s like to be a prescriber with Project Twenty21.

We also announce new events related to the project and medical cannabis more generally.

It’s been an incredibly exciting past month for the project. We have welcomed new clinics onto our Directory and been busy analysing the data, as more and more patients have had their follow-up appointments.

Today we are thrilled to be releasing our first findings from Project Twenty21. Our data shows that legally prescribed cannabis provides clinically significant improvements in the quality of life of patients living with conditions such as Chronic Pain, Multiple Sclerosis, Tourette’s Syndrome, Epilepsy, and Post Traumatic Stress Disorder (PTSD). Read the article and full report here.

The publication follows our recent paper which found that medical cannabis is among the most effective treatments for people with long-term, problematic neuropathic pain. Read the article and full report here.

Quotes

“Cannabis transformed my life from just about surviving in a painful pharmacological hazy nightmare, to thriving and living as well as I can and enjoying sleep, quality of life and my children again.”

“My anxiety, now I know I’m legal, is so much better just for that. I’m saving money and being able to live a life and not have to choose between meds or food. It’s simply amazing.”

What's it like being a T21 prescriber?

Dr Rebecca Moore tells all to Cannabis Health about why and how she joined T21, and what it’s like being a prescriber with the project.

Read the article and watch her interview here.

Dr Rebecca MooreConsultant Psychiatrist

On our YouTube channel, you can find our patient videos covering MS, Anxiety Disorder, PTSD, Tourette’s Syndrome, Chronic Pain and Ehlers Danlos syndrome.

Events

Ask A Scientist with Prof Mike Barnes: 13th May
Clinical Director of Project Twenty21 will be taking part in this free Q&A hosted by ScotSci, answering your questions about medical cannabis. Sign up here.

Prohibition Partners LIVE global cannabis conference: 18th-20th May
Following previous successful online events, Drug Science will once again be on the bill for this 3-day online conference, including a Fireside MP Chat with Prof David Nutt and panel discussions featuring our very own Dr Anne Schag and Prof Mike Barnes. Streaming tickets are free – get yours here.

Chronic Pain & Medical Cannabis – Project Twenty21 Research
(in collaboration with the British Pain Society): 18th May

Please note this event is for healthcare professionals only. Register for free here.
 

Legal but inaccessible – Medical Cannabis for Epilepsy: 27th May
It’s National Epilepsy Awareness Week, so where are we at with medical cannabis treatment for adults and children with Epilepsy in the UK? We have an expert panel discussing what has happened since legalisation in 2018, and why patient access is still so difficult. Register for free here.

Medical Cannabis Explained (for medical professionals): 3rd June
Our next CPD certified training session for medical professionals is a perfect opportunity for doctors to ask questions face-to-face with our Clinical Director, Prof Mike BarnesTo find out more and register, click here.

GCI Virtual Summit 2021: 8th-10th June
Drug Science CEO, David Badcock, will be taking part in a panel discussion: “Advocacy in the UK: Leveraging the Relationship Between Business, Medicine and Policy”. Find out more here.

We value your feedback and data

A study like T21 definitely comes with challenges. With this in mind, we kindly ask our patients to be respectful and patient when speaking to doctors and clinic staff. We continue to listen to your feedback and work hard to make improvements to patient access and support. Tell us about your experience by submitting your story here.
 
And remember that in order to provide medical cannabis at a reduced price, we MUST collect patient data every 3 months. So if you’re a T21 patient, please fill out your data questionnaires (sent via email) ideally 1-2 days before your appointment. This will give your doctor plenty of time during your appointment to focus on making sure your prescription is right for your needs.

How can you help?

As we receive more and more stories from patients, the importance of Project Twenty21 has never been clearer. If you’d like to support Project Twenty21, to help us gather evidence for medical cannabis to be covered by the NHS, please consider a donation to Drug Science

Every little bit helps us continue the essential work that we do.